Highly Promiscuous Small Molecules from Biological Screening Assays Include Many Pan-Assay Interference Compounds but Also Candidates for Polypharmacology

Journal of Medicinal Chemistry

Volumn 59, Issue 22, 2016, Pages 10285-10290

  Gilberg, Erik ^a   Jasial, Swarit ^a   Stumpfe, Dagmar ^a   Dimova, Dilyana ^a   Bajorath, Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND; MOLECULAR LIBRARY;

ARTICLE; ARTIFACT; BIOLOGICAL ACTIVITY; DRUG SCREENING; POLYPHARMACOLOGY; TAUTOMER; CHEMICAL STRUCTURE; CHEMISTRY; MOLECULAR LIBRARY; PRECLINICAL STUDY;

DRUG EVALUATION, PRECLINICAL; MOLECULAR STRUCTURE; POLYPHARMACOLOGY; SMALL MOLECULE LIBRARIES;

EID: 84999622591     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.6b01314     Document Type: Article

References (29)

1. Paolini, G. V.; Shapland, R. H.; van Hoorn, W. P.; Mason, J. S.; Hopkins, A. L. Global Mapping of Pharmacological Space Nat. Biotechnol. 2006, 24, 805-815 10.1038/nbt1228
2. Boran, A. D.; Iyengar, R. Systems Approaches to Polypharmacology and Drug Discovery Curr. Opin. Drug Discovery Dev. 2010, 13, 297-309
3. Jalencas, X.; Mestres, J. On the Origins of Drug Polypharmacology MedChemComm 2013, 4, 80-87 10.1039/C2MD20242E
4. Hu, Y.; Bajorath, J. Compound Promiscuity-What Can We Learn From Current Data Drug Discovery Today 2013, 18, 644-650 10.1016/j.drudis.2013.03.002
5. Hu, Y.; Bajorath, J. High-Resolution View of Compound Promiscuity F1000Research 2013, 2, 144 10.12688/f1000research.2-144.v1
6. McGovern, S. L.; Caselli, E.; Grigorieff, N. A.; Shoichet, B. K. Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening J. Med. Chem. 2002, 45, 1712-1722 10.1021/jm010533y
7. Shoichet, B. K. Screening in a Spirit Haunted World Drug Discovery Today 2006, 11, 607-615 10.1016/j.drudis.2006.05.014
8. Baell, J. B.; Holloway, G. A. New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays J. Med. Chem. 2010, 53, 2719-2740 10.1021/jm901137j
9. Baell, J. B.; Walters, M. A. Chemistry: Chemical Con Artists Foil Drug Discovery Nature 2014, 513, 481-483 10.1038/513481a
10. Baell, J. B.; Ferrins, L.; Falk, H.; Nikolakopoulos, G. PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening Aust. J. Chem. 2013, 66, 1483-1494 10.1071/CH13551
11. Saubern, S.; Guha, R.; Baell, J. B. KNIME Workflow to Asses PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Chemoinformatics Libraries Mol. Inf. 2011, 30, 847-850 10.1002/minf.201100076
12. RDKit: Cheminformatics and Machine Learning Software; RDKit, 2013; http://www.rdkit.org.
13. Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; Overington, J. P. ChEMBL: A Large-Scale Bioactivity Database for Drug Discovery Nucleic Acids Res. 2012, 40, D1100-D1107 10.1093/nar/gkr777
14. Sterling, T.; Irwin, J. J. ZINC 15 - Ligand Discovery for Everyone J. Chem. Inf. Model. 2015, 55, 2324-2337 10.1021/acs.jcim.5b00559
15. Irwin, J. J.; Duan, D.; Torosyan, H.; Doak, A. K.; Ziebart, K. T.; Sterling, T.; Tumanian, G.; Shoichet, B. K. An Aggregation Advisor for Ligand Discovery J. Med. Chem. 2015, 58, 7076-7087 10.1021/acs.jmedchem.5b01105
16. Wang, Y.; Xiao, J.; Suzek, T. O.; Zhang, J.; Wang, J.; Zhou, Z.; Han, L.; Karapetyan, K.; Dracheva, S.; Shoemaker, B. A.; Bolton, E.; Gindulyte, A.; Bryant, S. H. PubChem's BioAssay Database Nucleic Acids Res. 2012, 40, D400-D412 10.1093/nar/gkr1132
17. Jasial, S.; Hu, Y.; Bajorath, J. Determining the Degree of Promiscuity of Extensively Assayed Compounds PLoS One 2016, 11, e0153873 10.1371/journal.pone.0153873
18. Stumpfe, D.; Dimova, D.; Bajorath, J. Computational Method for the Systematic Identification of Analog Series and Key Compounds Representing Series and Their Biological Activity Profiles J. Med. Chem. 2016, 59, 7667-7676 10.1021/acs.jmedchem.6b00906
19. Henry, B.; Foti, C.; Alsante, K. Can Light Absorption and Photostability Data be Used to Assess the Photosafety Risks in Patients for a New Drug Molecule? J. Photochem. Photobiol., B 2009, 96, 57-62 10.1016/j.jphotobiol.2009.04.005
20. Pharmacy Compounding. Code of Federal Regulations, Section 216.24, Title 21, 2016.
21. Sanchez, J. P. A Ring Opening Reaction of Benzisothiazolones. A New Route to Unsymmetrical Disulfides J. Heterocycl. Chem. 1997, 34, 1463-1467 10.1002/jhet.5570340515
22. Lyss, G.; Knorre, A.; Schmidt, T. J.; Pahl, H. L.; Merfort, I. The Anti-Inflammatory Sqesuiterpene Lactone Helenalin Inhibits the Transcription Factor NF-kappaB by Directly Targeting p65 J. Biol. Chem. 1998, 273, 33508-33516 10.1074/jbc.273.50.33508
23. Arróniz, C.; Molina, J.; Abás, S.; Molins, E.; Campanera, J. M.; Luque, F. J.; Escolano, C. First Diastereoselective [3 + 2] Cycloaddition Reaction of Diethyl Isocyanomethylphosphonate and Maleimides Org. Biomol. Chem. 2013, 11, 1640-1649 10.1039/c3ob26766k
24. Dahlin, J. L.; Nissink, W. M.; Strasser, J. M.; Francis, S.; Higgins, L.; Zhou, H.; Zhang, Z.; Walters, M. A. PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS J. Med. Chem. 2015, 58, 2091-2113 10.1021/jm5019093
25. Tabrizi, L.; Fooladivanda, M.; Chiniforoshan, H. Copper(II), Cobalt(II) and Nickel(II) Complexes of Juglone: Synthesis, Structure, DNA Interaction and Enhanced Cytotoxicity BioMetals 2016, 10.1007/s10534-016-9970-0
26. Anastassiadis, T.; Deacon, S. W.; Devarajan, K.; Ma, H.; Peterson, J. R. Comprehensive Assay of Kinase Catalytic Activity Reveals Features of Kinase Inhibitor Selectivity Nat. Biotechnol. 2011, 29, 1039-1045 10.1038/nbt.2017
27. Olson, M. E.; Abate-Pella, D.; Perkins, A. L.; Li, M.; Carpenter, M. A.; Rathore, A.; Harris, R. S.; Harki, D. A. Oxidative Reactivities of 2-Furylquinolines: Ubiquitous Scaffolds in Common High-Throughput Screening Libraries J. Med. Chem. 2015, 58, 7419-7430 10.1021/acs.jmedchem.5b00930
28. Senger, M. R.; Fraga, C. A. M.; Dantas, R. F.; Silva, F. P., Jr. Filtering Promiscuous Compounds in Early Drug Discovery: Is It a Good Idea? Drug Discovery Today 2016, 21, 868-872 10.1016/j.drudis.2016.02.004
29. https://zenodo.org/record/164405